MEDICINES
PATIENT ASSISTANCE PROGRAMS
IMPORTED MEDICINES
CONTACT US
Upload
Introduction to Rahika 150mg Tablet
Rahika 150mg tablet contains Capmatinib, an anti-cancer medication classified as a protein kinase inhibitor. It is prescribed for adults with non-small cell lung cancer (NSCLC) that has either spread to other parts of the body or is associated with a mutation in the MET gene.
Do not take Rahika 150mg if you are allergic to this medication or any of its ingredients. Inform your doctor if you have or have had lung or breathing issues unrelated to your lung cancer, liver problems, or pancreatic disorders. Additionally, notify your physician if you experience any symptoms of an allergic reaction, such as rash, hives, fever, difficulty breathing, or low blood pressure. This medicine is not recommended for children and adolescents under 18 years of age.
Uses of Rahika 150mg Tablet
- Non-small cell lung cancer (NSCLC)
Therapeutic Effects of Rahika 150mg Tablet
Rahika 150mg tablet is a kinase inhibitor that targets mesenchymal-epithelial transition (MET). It works by blocking the action of this abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
Interaction of Rahika 150mg Tablet with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, vaccinations, nutritional and vitamin supplements, and herbal products. Certain medications interact with Rahika 150mg tablet and reduce its effectiveness by causing undesirable side effects.
More Information about Rahika 150mg Tablet
- Store at 20°C to 25°C
- Protect the medicine from light and excessive moisture.
- Keep the medicine out of reach of children and pets
- If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
How to consume Rahika 150mg Tablet
It is an orally available prescription drug. Your doctor will decide the dose and duration of Rahika 150mg tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water.
Safety Advices
Pregnancy
Tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 7 days after your last dose.
Breast Feeding
Breastfeeding is not recommended in patients taking tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Lungs
Tablet should be cautiously administered in patients with lung problems other than lung cancer. Inform your physician if you have any lung diseases before initiating the therapy.
Liver
Tablet should be used cautiously in patients with liver problems. Dose adjustments are necessary for liver failure patients. Inform your physician if you have any liver diseases before initiating the therapy.
Alcohol
It is unknown whether it is safe to consume alcohol with tablet. Please consult your doctor.
Driving
It is unknown whether Tablet alters the ability to drive or operate heavy machinery. If you feel dizzy or sleepy, avoid driving and consult your doctor.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
- Vomiting
- Liver injury
- Muscle pain
- Shortness of breath
- Lung infection
- Respiratory disease
Common
- Swelling in the face, and body
- Decrease in appetite
- Nausea
- Cough
- Fatigue
Word of Advice
Limit direct exposure to the sun or artificial ultraviolet (UV) light while using this medicine. Use sunscreen, wear sunglasses and protective clothing while you are going outdoors, and for at least 7 days after you stop taking it. Report immediately to your doctor if you have abdominal pain. This medicine may cause birth defects if either partner is using it during conception or pregnancy. If you are a female patient with reproductive potential, use an effective form of birth control during the treatment and for 1 week after the last dose. Male patients with female partners should use an effective form of birth control during treatment and for at least 1 week after the last dose. Do not breastfeed while using this medicine and for at least 1 week after your last dose. Your doctor may do lab tests to check the therapy’s effectiveness or monitor the unwanted side effects.
FAQs
Q 1. What should I tell my healthcare provider before taking Rahika 150mg tablet?
Inform your physician about all your medical and medication history, including over-the-counter medicines and nutritional or vitamin supplements you are taking.
Q 2. How long do I have to take Rahika 150mg tablet?
The duration of your treatment depends on your disease condition and severity. Your doctor will decide your dose, and duration of your treatment.
Q 3. Can Rahika 150mg tablet given to kidney failure patients?
Yes, Rahika 150mg tablet is safe when prescribed to patients with kidney diseases. No dose adjustments are necessary. Inform your physician if you have any kidney diseases before initiating the treatment.
Fact Box
Molecule name: Capmatinib
Pharmacological class: Protein Kinase Inhibitors
Therapeutic class: Anti-cancer
Indications: Non-small cell lung cancer (NSCLC)
Reviews
There are no reviews yet.